Protext Mobility Inc
OTC:TXTM
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
|
Protext Mobility Inc
OTC:TXTM
|
42.2m USD |
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
409.8B USD |
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
198.7B USD |
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
193.1B USD |
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
124.5B USD |
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
84.3B USD |
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
72.6B AUD |
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43.1B EUR |
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Market Distribution
| Min | -4 418 600% |
| 30th Percentile | -9.6% |
| Median | 3.1% |
| 70th Percentile | 11.3% |
| Max | 1 135 400% |
Other Profitability Ratios
Protext Mobility Inc
Glance View
ProText Mobility, Inc. engages in the development of pharmaceutical applications for botanical drugs. The company is headquartered in Delray Beach, Florida. The company went IPO on 2003-08-21. The firm is engaged in the research, clinical testing and commercialization of bioavailable botanical products, which includes all-natural ingredients formulated for nutraceutical and pharmaceutical applications. The firm is focused on the development of pharmaceutical applications for botanical drugs and has the license to develop Phytofare in botanical drug applications. The Phytofare is bioavailable extract produced from live green tea leaves that has been clinically proven in double-blind human trials to have greater bioavailability over generic extract. The Company’s subsidiaries include EchoMetrix, Plandai Biotechnology and Cannabis Biosciences, Inc.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
Over the last 3 years, Protext Mobility Inc’s Net Margin has decreased from -17 300% to -276 562.5%. During this period, it reached a low of -319 800% on Dec 31, 2013 and a high of -8 075% on Mar 31, 2012.
